The Determinants of Healthcare Cost for Glaucoma Patients in Cicendo Eye Hospital, Bandung, Indonesia
Abstract
Glaucoma is the second foremost cause of impaired vision. People whosuffered from Glaucoma face the independent expenditure for thetreatment as blind people with Glaucoma could not be cured perfectly.This study intends to analyze the effect of age, types of patient care, typesof Glaucoma, and types of payment on the total cost of care of glaucomapatients at Cicendo Eye Hospital, Bandung, Indonesia. This study uses3,358 patient medical records of Cicendo Eye Hospital, Bandung,Indonesia, in 2018. The 3,358 samples were selected from the patient’smedical record based on patients’ categories indicated or convicted ofhaving Glaucoma. Robust Linear Regression is applied in this study tomeasure the additional cost for Glaucoma treatment. The results showedthat the total cost of patient care was positively and significantly affectedby hospitalization status (p=0.000), age (p=0.000), times of treatment(p=0.000), having primary glaucoma (p=0.000), having congenitalglaucoma (p=0.000), and presence of intraocular (p=0.000). Conversely,patient care’s total cost was negatively and significantly affected usinginsurance (p=0.082). This result would be a precautionary measure forthe medical institution to consider better financial planning, servicedelivery improvement, and the patient’s payment scheme effectiveness.
References
1. Flaxman SR, Bourne RRA, Resnikoff S, et al. Global Causes of Blindness and Distance Vision Impairment 1990–2020: A Systematic Review and Meta-Analysis. The Lancet Global Health. 2017;5(12):1221-1234.
2. Liu SA, Zhao ZN, Sun NN, Han Y, Chen J, Fan ZG. Transitions of the Understanding and Definition of Primary Glaucoma. Chinese Medical Journal. 2018;131(23):2852-2859.
3. Kapetanakis V V., Chan MPY, Foster PJ, Cook DG, Owen CG, Rudnicka AR. Global Variations and Time Trends in the Prevalence of Primary Open Angle Glaucoma (POAG): A Systematic Review and Meta Analysis. British Journal of Ophthalmology. 2016;100(1):86-93.
4. Sun X, Dai Y, Chen Y, et al. Primary Angle Closure Glaucoma: What We Know and What We Don’t Know. Progress in Retinal and Eye Research. 2017;57:26-45.
5. Sakti ES, Prahasta A, Lestari S, Mildya F. Situasi Glaukoma di Indonesia. Published online 2019:1-2.
6. Song P, Wang J, Bucan K, Theodoratou E, Rudan I, Chan KY. National and Subnational Prevalence and Burden of Glaucoma in China: A Systematic Analysis. Journal of Global Health. 2017;7(2):020705.
7. Lazcano-Gomez G, De Los Angeles Ramos Cadena M, Torres-Tamayo M, De Oteyza AH, Turati Acosta M, Jimenez-Román J. Cost of Glaucoma Treatment in a Developing Country Over a 5-Year Period. Medicine. 2016;95(47):1-5.
8. Hegde SP, Sekharreddy MR, Kumar MR, Dayanidhi VK. Prospective Study of Hypermature Cataract in Kanchipuram District: Causes of Delayed Presentation, Risk of Lens-Induced Glaucoma and Visual Prognosis. Kerala Journal of Ophthalmology. 2018;30(3):187-192.
9. Yu C, Yao W. Robust Linear Regression: A Review and Comparison. Communications in Statistics: Simulation and Computation. 2017;46(8):6261-6282.
10. Ribeiro F, Ferreira T, Feijóo B, et al. Improving Outcomes with Multifocal Intraocular Lenses: Managing Glaucoma and Macular Evaluation. Revista Sociedade Portuguesa de Oftalmologia. 2016;40(3):193-198.
11. Gomaa AS, Birch JB. A Semiparametric Nonlinear Mixed Model Approach to Phase I Profile Monitoring. Communications in Statistics: Simulation and Computation. 2019;48(6):1677-1693.
12. El-Medany A, Jeganathan VSE, Tatham AJ. Severity of Glaucoma at First Presentation to Hospital Eye Services. International Journal of Open Access Ophthalmology. 2017;2(1):1-5.
13. Lin B, Li Y, Zhang W, et al. Influencing Factors of Hospitalization Costs for Glaucoma Patients Under Clinical Pathway Mana-gement. Annals of Eye Science. 2019;4(8):36.
14. McGinley P, Ansari E, Sandhu H, Dixon T. The Cost Burden of Falls in People With Glaucoma in National Health Service Hospital Trusts in the UK. Journal of Medical Economics. 2020;23(1):106-112.
15. Mandal AK, Senthil S. Childhood Glaucoma Surgery in Developing Countries. Surgical Management of Childhood Glaucoma. Springer, Cham. 2018: 159-171.
16. Liu D, Huang L, Mukkamala L, Khouri AS. The Economic Burden of Childhood Glaucoma. Journal of Glaucoma. 2016;25(10):790-797.
17. Azuara-Blanco A, Burr J, Ramsay C, et al. Effectiveness of Early Lens Extraction for the Treatment of Primary Angle Closure Glaucoma (EAGLE): A Randomised Controlled Trial. The Lancet. 2016;388(10052):1389-1397.
18. Javanbakht M, Azuara-Blanco A, Burr JM, et al. Early Lens Extraction with Intraocular Lens Implantation for the Treatment of Primary Angle Closure Glaucoma: An Economic Evaluation Based on Data from The EAGLE Trial. BMJ Open. 2017;7(1):1-12.
19. Nayak B, Gupta S, Kumar G, Dada T, Gupta V, Sihota R. Socioeconomics of Long-Term Glaucoma Therapy in India. Indian Journal of Ophthalmology. 2015;63(1):20-24.
20. Puspasari H, Suryaningrat D, Rizky M. Analisis Biaya Pengobatan Pasien Diagnosa Demam Tifoid di Instalasi Rawat Inap RSUD Dr Soedarso Pontianak Tahun 2018. Jurnal Farmasi dan Ilmu Kefarmasian Indonesia. 2020;7(1):1-6.
2. Liu SA, Zhao ZN, Sun NN, Han Y, Chen J, Fan ZG. Transitions of the Understanding and Definition of Primary Glaucoma. Chinese Medical Journal. 2018;131(23):2852-2859.
3. Kapetanakis V V., Chan MPY, Foster PJ, Cook DG, Owen CG, Rudnicka AR. Global Variations and Time Trends in the Prevalence of Primary Open Angle Glaucoma (POAG): A Systematic Review and Meta Analysis. British Journal of Ophthalmology. 2016;100(1):86-93.
4. Sun X, Dai Y, Chen Y, et al. Primary Angle Closure Glaucoma: What We Know and What We Don’t Know. Progress in Retinal and Eye Research. 2017;57:26-45.
5. Sakti ES, Prahasta A, Lestari S, Mildya F. Situasi Glaukoma di Indonesia. Published online 2019:1-2.
6. Song P, Wang J, Bucan K, Theodoratou E, Rudan I, Chan KY. National and Subnational Prevalence and Burden of Glaucoma in China: A Systematic Analysis. Journal of Global Health. 2017;7(2):020705.
7. Lazcano-Gomez G, De Los Angeles Ramos Cadena M, Torres-Tamayo M, De Oteyza AH, Turati Acosta M, Jimenez-Román J. Cost of Glaucoma Treatment in a Developing Country Over a 5-Year Period. Medicine. 2016;95(47):1-5.
8. Hegde SP, Sekharreddy MR, Kumar MR, Dayanidhi VK. Prospective Study of Hypermature Cataract in Kanchipuram District: Causes of Delayed Presentation, Risk of Lens-Induced Glaucoma and Visual Prognosis. Kerala Journal of Ophthalmology. 2018;30(3):187-192.
9. Yu C, Yao W. Robust Linear Regression: A Review and Comparison. Communications in Statistics: Simulation and Computation. 2017;46(8):6261-6282.
10. Ribeiro F, Ferreira T, Feijóo B, et al. Improving Outcomes with Multifocal Intraocular Lenses: Managing Glaucoma and Macular Evaluation. Revista Sociedade Portuguesa de Oftalmologia. 2016;40(3):193-198.
11. Gomaa AS, Birch JB. A Semiparametric Nonlinear Mixed Model Approach to Phase I Profile Monitoring. Communications in Statistics: Simulation and Computation. 2019;48(6):1677-1693.
12. El-Medany A, Jeganathan VSE, Tatham AJ. Severity of Glaucoma at First Presentation to Hospital Eye Services. International Journal of Open Access Ophthalmology. 2017;2(1):1-5.
13. Lin B, Li Y, Zhang W, et al. Influencing Factors of Hospitalization Costs for Glaucoma Patients Under Clinical Pathway Mana-gement. Annals of Eye Science. 2019;4(8):36.
14. McGinley P, Ansari E, Sandhu H, Dixon T. The Cost Burden of Falls in People With Glaucoma in National Health Service Hospital Trusts in the UK. Journal of Medical Economics. 2020;23(1):106-112.
15. Mandal AK, Senthil S. Childhood Glaucoma Surgery in Developing Countries. Surgical Management of Childhood Glaucoma. Springer, Cham. 2018: 159-171.
16. Liu D, Huang L, Mukkamala L, Khouri AS. The Economic Burden of Childhood Glaucoma. Journal of Glaucoma. 2016;25(10):790-797.
17. Azuara-Blanco A, Burr J, Ramsay C, et al. Effectiveness of Early Lens Extraction for the Treatment of Primary Angle Closure Glaucoma (EAGLE): A Randomised Controlled Trial. The Lancet. 2016;388(10052):1389-1397.
18. Javanbakht M, Azuara-Blanco A, Burr JM, et al. Early Lens Extraction with Intraocular Lens Implantation for the Treatment of Primary Angle Closure Glaucoma: An Economic Evaluation Based on Data from The EAGLE Trial. BMJ Open. 2017;7(1):1-12.
19. Nayak B, Gupta S, Kumar G, Dada T, Gupta V, Sihota R. Socioeconomics of Long-Term Glaucoma Therapy in India. Indian Journal of Ophthalmology. 2015;63(1):20-24.
20. Puspasari H, Suryaningrat D, Rizky M. Analisis Biaya Pengobatan Pasien Diagnosa Demam Tifoid di Instalasi Rawat Inap RSUD Dr Soedarso Pontianak Tahun 2018. Jurnal Farmasi dan Ilmu Kefarmasian Indonesia. 2020;7(1):1-6.
Authors
Rizki, R. N., & Sihaloho, E. D. (2020). The Determinants of Healthcare Cost for Glaucoma Patients in Cicendo Eye Hospital, Bandung, Indonesia. Media Kesehatan Masyarakat Indonesia, 16(4), 500-508. https://doi.org/10.30597/mkmi.v16i4.9745
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.